Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Do you consider a stock's sales trends when comparing names? For ideas on how to start your own sales analysis, we ran a screen.

We began by screening the healthcare sector for stocks currently rallying above their 20-day, 50-day, and 200-day moving averages, indicating that these stocks have strong upward momentum.

We then screened for strong sales trends by comparing their growth in revenue to growth in inventory over the last year. We screened for stocks with positive sales trends, with faster growth in revenue than inventory over the last year. Since inventory represents the portion of goods not yet sold, faster growth in revenue than inventory is considered an encouraging sign.

To screen for strengthening liquidity, we also only focused on those companies with inventory decreasing as a percent of current assets.

(click to enlarge)

Tool provided by Kapitall.

Do you think these stocks will continue to rise? Use this list as a starting point for your own analysis.

List sorted by increase in revenue over the last year.

1. Cyberonics Inc. (NASDAQ:CYBX): Engages in the design, development, manufacture, sale, and marketing of implantable medical devices that provide vagus nerve stimulation therapy for the treatment of refractory epilepsy and treatment-resistant depression. Market cap at $1.06B, most recent closing price at $38.48. The stock is currently trading 0.20% above its 20-day moving average, 1.51% above its 50-day MA, and 14.17% above its 200-day MA. Revenue grew by 15.85% during the most recent quarter ($54.54M vs. $47.08M y/y). Inventory grew by -11.32% during the same time period ($13.95M vs. $15.73M y/y). Inventory, as a percentage of current assets, decreased from 10.98% to 10.33% during the most recent quarter (comparing 13 weeks ending 2012-01-27 to 13 weeks ending 2011-01-28).

2. Trinity Biotech plc (NASDAQ:TRIB): Develops, manufactures, distributes, and sells diagnostic test kits and instrumentation worldwide. Market cap at $250.09M, most recent closing price at $11.43. The stock is currently trading 0.68% above its 20-day moving average, 3.37% above its 50-day MA, and 10.84% above its 200-day MA. Revenue grew by 7.4% during the most recent quarter ($20.03M vs. $18.65M y/y). Inventory grew by 3.54% during the same time period ($19.3M vs. $18.64M y/y). Inventory, as a percentage of current assets, decreased from 18.16% to 17.43% during the most recent quarter (comparing 3 months ending 2012-03-31 to 3 months ending 2011-03-31).

3. West Pharmaceutical Services, Inc. (NYSE:WST): Manufactures and sells components and systems for injectable drug delivery and plastic packaging, and delivery system components for the pharmaceutical, healthcare, and consumer products industries. Market cap at $1.62B, most recent closing price at $47.81. The stock is currently trading 5.91% above its 20-day moving average, 10.52% above its 50-day MA, and 20.18% above its 200-day MA. Revenue grew by 7.08% during the most recent quarter ($316.3M vs. $295.4M y/y). Inventory grew by 0.7% during the same time period ($158.2M vs. $157.1M y/y). Inventory, as a percentage of current assets, decreased from 32.65% to 31.46% during the most recent quarter (comparing 3 months ending 2012-03-31 to 3 months ending 2011-03-31).

4. Young Innovations Inc. (NASDAQ:YDNT): Engages in the development, manufacture, and marketing of supplies and equipment used by dentists, dental hygienists, dental assistants, and consumers primarily in the United States, as well as in Canada, Europe, South America, Central America, and the Pacific Rim. Market cap at $280.44M, most recent closing price at $35.71. The stock is currently trading 5.89% above its 20-day moving average, 10.36% above its 50-day MA, and 21.10% above its 200-day MA. Revenue grew by 2.81% during the most recent quarter ($26.75M vs. $26.02M y/y). Inventory grew by -3.26% during the same time period ($16.93M vs. $17.5M y/y). Inventory, as a percentage of current assets, decreased from 48.17% to 43.34% during the most recent quarter (comparing 3 months ending 2012-03-31 to 3 months ending 2011-03-31).

*Accounting data sourced from Google Finance, all other data sourced from Finviz.

Source: 4 Rallying Healthcare Stocks With Strong Inventory Trends